Publicacions en col·laboració amb investigadors/es de Clínica Universitaria de Navarra (24)

2015

  1. Level of IgG4 anti-desmoglein 3 antibodies correlates with disease activity in patients with pemphigus vulgaris

    AUTOIMMUNE AND INFECTIOUS DISEASE, Vol. 1, Núm. 1

2010

  1. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: Implications for antiangiogenic/antithrombotic strategies

    British Journal of Dermatology, Vol. 162, Núm. 2, pp. 350-356

2009

  1. Large evaluation of anti-cardiolipin and anti-β2 glycoprotein I assays: Results from the Autoimmunity Workshop of the Spanish Society of Immunology

    Inmunologia

  2. Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cycloph osphamide

    Actas Dermo-Sifiliograficas, Vol. 100, Núm. 2, pp. 113-120

2007

  1. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus- specific human CD8+ T cells

    Clinical and Experimental Immunology, Vol. 149, Núm. 1, pp. 87-96

  2. Ear, nose and throat manifestations in pemphigus vulgaris

    British Journal of Dermatology, Vol. 156, Núm. 4, pp. 733-737

2005

  1. Association between peripheral IFN-γ producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis

    Cytokine

  2. Neurohormonas y citocinas en la insuficiencia cardíaca. Correlación con la reserva de flujo coronario

    Revista Espanola de Cardiologia, Vol. 58, Núm. 11, pp. 1273-1277

2004

  1. Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression

    Scandinavian Journal of Immunology, Vol. 59, Núm. 6, pp. 553-558

2003

  1. Estrategias terapéuticas con vacunas idiotípicas en el tratamiento del linfoma folicular

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 6, Núm. 3, pp. 175-182

2002

  1. Secretion of cytokines, histamine and leukotrienes in chronic urticaria

    International Archives of Allergy and Immunology, Vol. 129, Núm. 3, pp. 254-260

1998

  1. Progressive decrease of CD8(high+) CD28+ CD57- cells with ageing

    Clinical and Experimental Immunology, Vol. 112, Núm. 1, pp. 48-51

1995

  1. Unusual bullous disorder with features of toxic epidermal necrolysis, bullous pemphigoid and cicatricial pemphigoid

    Clinical and Experimental Dermatology, Vol. 20, Núm. 1, pp. 65-69

1994

  1. The type of interaction with FcγR in human monocytes determines the efficiency of the generation of oxidative burst

    Immunology, Vol. 83, Núm. 1, pp. 148-154

1993

  1. Defective mononuclear phagocyte function in systemic lupus erythematosus: Relationship of FcRII (CD32) with intermediate cytoskeletal filaments

    Journal of Investigational Allergology and Clinical Immunology, Vol. 3, Núm. 2, pp. 86-91

1992

  1. Cytokines-endothelium interaction: its role in the thrombotic process

    Revista de medicina de la Universidad de Navarra, Vol. 37, Núm. 2, pp. 16-29

  2. The measurement of transforming growth factor type β (TGFβ) levels produced by peripheral blood mononuclear cells requires the efficient elimination of contaminating platelets

    Journal of Immunological Methods, Vol. 153, Núm. 1-2, pp. 151-159

1990

  1. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year

    Journal of Autoimmunity, Vol. 3, Núm. 5, pp. 625-638

1989

  1. MODIFICACIONES POR PROTEINA A ESTAFILOCOCICA E INTERFERON-GAMMA EN LA ACTIVIDAD CITOTOXICA NATURAL DE PACIENTES CON CANCER

    Revista Espanola de Fisiologia, Vol. 45, Núm. SUPPL., pp. 239-244

  2. PAPEL DEL SISTEMA DE CONTACTO PLASMATICO EN LA FISIOPATOLOGIA HUMANA

    Revista Espanola de Fisiologia, Vol. 45, Núm. SUPPL., pp. 233-238